Navigation Links
Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
Date:5/2/2012

SAN DIEGO, May 2, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), and Rempex Pharmaceuticals, a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, have partnered for the third annual Great Strides fundraising walk to benefit the Cystic Fibrosis (CF) Foundation through participation and donations. Synteract and Rempex (on behalf of Aptalis Pharma) are also working together on clinical trials to combat the disease.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

"Great Strides: Taking Steps To Cure Cystic Fibrosis" is the largest fundraising event held by the Cystic Fibrosis Foundation to raise money for CF research and care. Synteract and Rempex employees will participate in this walk-a-thon on Sunday, May 6 at the Powerhouse Park in Del Mar to help fund a cure for the disease. The three-mile walk will bring co-workers, friends and families together in support of the work of the Cystic Fibrosis Foundation. Employees from both teams increased their fundraising efforts by hosting educational events and internal activities to raise additional donations. This is the second year the two companies have participated in the walk.

"Synteract and Rempex are pleased to be able to help the Cystic Fibrosis Foundation in its fundraising efforts and education of the community about such debilitating diseases," said Stewart Bieler, Chief Operating Officer at Synteract. "With the support of our team walkers, we are participating in the foundation's efforts to fight Cystic Fibrosis and help find a cure."

CF is an inherited chronic disease that affects the lungs and digestive systems of about 30,000 children and adults in the United States. There are about 1,000 new cases diagnosed with the disease each year. The Cystic Fibrosis Foundation has been fighting to find a cure and welcomes supporters like Synteract and Rempex.

Those who are interested in donating to the foundation or participating in the walk can contact Synteract representative Kathy Kaplan at 760-268-8200 or the Cystic Fibrosis Foundation at www.cff.org.

About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology.

CONTACT:
Antonia Genov
Clearpoint Agency, for Synteract
antonia@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Synteract Expands Executive Roles to Support Growth
2. Synteract Hosting CDISC Classes on Regulatory Data Standards, Feb. 21-24, in California
3. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
4. Synteract Releases SynCapture Version 1.5 of Its Hybrid Electronic Data Capture (EDC) System
5. Rempex Announces Series B Financing of Up to $67.5 Million
6. Medical Guardian Announces Social Media Partnership with Senior Citizen Charity
7. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
8. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
9. Heraeus Venus White® Brand Named the Official Whitening Fundraising Partner of Give Back a Smile
10. 99 Cents Only Stores Partners with the Red Cross to Help Local Residents Prepare for the Big One
11. Ametros Financial and Ringler Medicare Solutions Announce Partnership to Provide Professional Administration Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) announced today ... Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, value-based care, and ... analytics solutions. , “I am thrilled to welcome Dr. Spiro to BHI,” said ...
(Date:8/16/2017)... ... 16, 2017 , ... The Data Council, the leading provider ... acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the Specialty, ... leading suppliers, brokers, distributors and retailers. The Data Council will become a part ...
(Date:8/16/2017)... York, New York (PRWEB) , ... August 16, 2017 , ... ... they could minimize its appearance with diet and exercise. In fact, cellulite can't always ... is a safer and more effective treatment available to select physicians nationwide. Dr. Kenneth ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Southeastern ... three-year grant totaling $975,000, renewing its funding from the Health Resources and Services ... This funding marks, the fourth time the HRSA administration has renewed its financial ...
(Date:8/16/2017)... , ... August 16, 2017 , ... With a new ... and ultimately, a cure. , The grants are awarded through a competitive application ... with a wide array of backgrounds and expertise in all areas relevant to PD ...
Breaking Medicine News(10 mins):